191 related articles for article (PubMed ID: 19696876)
1. Investigating CTL mediated killing with a 3D cellular automaton.
Graw F; Regoes RR
PLoS Comput Biol; 2009 Aug; 5(8):e1000466. PubMed ID: 19696876
[TBL] [Abstract][Full Text] [Related]
2. A general functional response of cytotoxic T lymphocyte-mediated killing of target cells.
Gadhamsetty S; Marée AF; Beltman JB; de Boer RJ
Biophys J; 2014 Apr; 106(8):1780-91. PubMed ID: 24739177
[TBL] [Abstract][Full Text] [Related]
3. Estimating the In Vivo Killing Efficacy of Cytotoxic T Lymphocytes across Different Peptide-MHC Complex Densities.
Garcia V; Richter K; Graw F; Oxenius A; Regoes RR
PLoS Comput Biol; 2015 May; 11(5):e1004178. PubMed ID: 25933039
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous, delayed-onset killing by multiple-hitting T cells: Stochastic simulations to assess methods for analysis of imaging data.
Beck RJ; Bijker DI; Beltman JB
PLoS Comput Biol; 2020 Jul; 16(7):e1007972. PubMed ID: 32658891
[TBL] [Abstract][Full Text] [Related]
5. Estimation of the rate of killing by cytotoxic T lymphocytes in vivo.
Regoes RR; Barber DL; Ahmed R; Antia R
Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1599-603. PubMed ID: 17242364
[TBL] [Abstract][Full Text] [Related]
6. Spatial heterogeneity and peptide availability determine CTL killing efficiency in vivo.
Hogan T; Kadolsky U; Tung S; Seddon B; Yates A
PLoS Comput Biol; 2014 Sep; 10(9):e1003805. PubMed ID: 25233372
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms and Dynamics of T Cell-Mediated Cytotoxicity In Vivo.
Halle S; Halle O; Förster R
Trends Immunol; 2017 Jun; 38(6):432-443. PubMed ID: 28499492
[TBL] [Abstract][Full Text] [Related]
8. Mathematical models of cytotoxic T-lymphocyte killing.
Regoes RR; Yates A; Antia R
Immunol Cell Biol; 2007 Jun; 85(4):274-9. PubMed ID: 17420769
[TBL] [Abstract][Full Text] [Related]
9. A three-dimensional organotypic assay to measure target cell killing by cytotoxic T lymphocytes.
Weigelin B; Friedl P
Biochem Pharmacol; 2010 Dec; 80(12):2087-91. PubMed ID: 20849829
[TBL] [Abstract][Full Text] [Related]
10. A Sigmoid Functional Response Emerges When Cytotoxic T Lymphocytes Start Killing Fresh Target Cells.
Gadhamsetty S; Marée AFM; Beltman JB; de Boer RJ
Biophys J; 2017 Mar; 112(6):1221-1235. PubMed ID: 28355549
[TBL] [Abstract][Full Text] [Related]
11. How is the effectiveness of immune surveillance impacted by the spatial distribution of spreading infections?
Kadolsky UD; Yates AJ
Philos Trans R Soc Lond B Biol Sci; 2015 Aug; 370(1675):. PubMed ID: 26150655
[TBL] [Abstract][Full Text] [Related]
12. In Vivo Killing Capacity of Cytotoxic T Cells Is Limited and Involves Dynamic Interactions and T Cell Cooperativity.
Halle S; Keyser KA; Stahl FR; Busche A; Marquardt A; Zheng X; Galla M; Heissmeyer V; Heller K; Boelter J; Wagner K; Bischoff Y; Martens R; Braun A; Werth K; Uvarovskii A; Kempf H; Meyer-Hermann M; Arens R; Kremer M; Sutter G; Messerle M; Förster R
Immunity; 2016 Feb; 44(2):233-45. PubMed ID: 26872694
[TBL] [Abstract][Full Text] [Related]
13. Revisiting estimates of CTL killing rates in vivo.
Yates A; Graw F; Barber DL; Ahmed R; Regoes RR; Antia R
PLoS One; 2007 Dec; 2(12):e1301. PubMed ID: 18074025
[TBL] [Abstract][Full Text] [Related]
14. What do mathematical models tell us about killing rates during HIV-1 infection?
Gadhamsetty S; Beltman JB; de Boer RJ
Immunol Lett; 2015 Nov; 168(1):1-6. PubMed ID: 26279491
[TBL] [Abstract][Full Text] [Related]
15. Individual Human Cytotoxic T Lymphocytes Exhibit Intraclonal Heterogeneity during Sustained Killing.
Vasconcelos Z; Müller S; Guipouy D; Yu W; Christophe C; Gadat S; Valitutti S; Dupré L
Cell Rep; 2015 Jun; 11(9):1474-85. PubMed ID: 26027932
[TBL] [Abstract][Full Text] [Related]
16. Notwithstanding Circumstantial Alibis, Cytotoxic T Cells Can Be Major Killers of HIV-1-Infected Cells.
Gadhamsetty S; Coorens T; de Boer RJ
J Virol; 2016 Aug; 90(16):7066-7083. PubMed ID: 27226367
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Microtubule-Network Rescues CTL Killing Efficiency in Dense 3D Matrices.
Zhao R; Zhou X; Khan ES; Alansary D; Friedmann KS; Yang W; Schwarz EC; Del Campo A; Hoth M; Qu B
Front Immunol; 2021; 12():729820. PubMed ID: 34484240
[TBL] [Abstract][Full Text] [Related]
18. How many human immunodeficiency virus type 1-infected target cells can a cytotoxic T-lymphocyte kill?
Wick WD; Yang OO; Corey L; Self SG
J Virol; 2005 Nov; 79(21):13579-86. PubMed ID: 16227278
[TBL] [Abstract][Full Text] [Related]
19. Blocking of CTL-mediated killing by monoclonal antibodies to LFA-1 and Lyt-2, 3. II. Evidence that trypsin pretreatment of target cells removes a non-H-2 molecule important in killing.
Gromkowski SH; Heagy W; Martz E
J Immunol; 1985 Jan; 134(1):70-7. PubMed ID: 3880579
[TBL] [Abstract][Full Text] [Related]
20. Contact-Dependent Killing by Cytotoxic T Lymphocytes Is Insufficient for EL4 Tumor Regression
Beck RJ; Slagter M; Beltman JB
Cancer Res; 2019 Jul; 79(13):3406-3416. PubMed ID: 31040155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
